Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday

Photo by Chris Montgomery on Unsplash

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

This year’s Life Sciences Investor Forum, running from 9:30 a.m. to 3:30 p.m. Dec. 16, introduces 12 publicly listed life science companies aiming to improve the quality of human life.

From biopharmaceuticals and epigenetics to psychedelics and metabolic health, each company has chosen a niche through which to achieve this goal. Attendees, investors and stakeholders will watch and listen as each of these companies explains their latest ideas, prompting watchers to wonder: What new scientific development will change human life as we know it?

For ReShape Lifesciences Inc. RSLS, the answer to this question may reportedly lie in its Food and Drug Administration (FDA)-approved Lap-Band® Program, which provides a minimally invasive, long-term treatment for obesity. Meanwhile, VolitionRx Ltd. VNRX will argue that its Nucleosomicsplatform will radically improve patients’ ability to catch and monitor life-changing diseases early. Mind Cure Health Inc. MCURF will posit that its research on the effect of digital therapeutics and psychedelic compounds on mental health will challenge our understanding of conventional mental health therapy. Nine more companies will post their arguments, but investors will only get to hear the full story at the forum.

The Life Science Investor Forum may present a window of opportunity for investors and traders, allowing them to hear exclusively from companies attempting to be health leaders of the future. The 1-day marathon event is free for everyone and requires only a simple email sign-up to join. 

Life Sciences Investor Forum Agenda

A complete list of the agenda is available on the Life Science Investor Forum’s main page.

Time: 9:30 a.m. EST 

Company: RedHill BioPharma Ltd. 

Ticker: RDHL 

Industry: Biopharmaceuticals — gastrointestinal and infectious diseases

Speaker information: Guy Goldberg, Chief Business Officer

Time: 10 a.m. EST 

Company: RespireRx Pharmaceuticals Inc. 

Ticker: RSPI 

Industry: Biopharmaceuticals — psychiatric and neurological disorders

Speaker information: Jeff Margolis, SVP, Treasurer, CFO and Member of Board of Directors

Time: 10:30 a.m. EST 

Company: Relief Therapeutics Holding SA

Ticker: RLFTF

Industry: Biopharmaceuticals — respiratory and rare and specialty

Speaker information: Jack Weinstein, chief financial officer and treasurer

Time: 11 a.m. EST 

Company: VolitionRx Limited

Ticker: VNRX 

Industry: Epigenetics — cancer screening and veterinary 

Speaker information: Scott Powell, head of investor relations and U.S. chief financial officer

Time: 11:30 a.m. EST 

Company: Mind Cure Health Inc.

Ticker: MCURF 

Industry: Pharmaceuticals —  psychedelics and mental health

Speaker Information: Kelsey Ramsden, president and CEO

Time: 12 p.m. EST 

Company: Alpha Cognition, Inc.

Tickers: ACOGF, ACOG 

Industry: Biopharmaceuticals — Alzheimer’s disease and amyotrophic lateral sclerosis (ALS)

Speaker information: Michael McFadden, CEO

Time: 12:30 p.m. EST 

Company: Emmaus Life Sciences Inc.

Ticker: EMMA 

Industry: Biopharmaceuticals — rare and orphan diseases 

Speaker information: Yutaka Niihara, CEO and chairman

Time: 1 p.m. EST 

Company: Hemostemix Inc. 

Tickers: HMTXF, HEM 

Industry: Biotechnology — stem cell therapies

Speaker information: Thomas Smeenk, co-founder, president and CEO

Time: 1:30 p.m. EST 

Company: Jack Nathan Medical Corp.

Tickers: JNHMF, (TSX:-V JNH) 

Industry: Primary-care medical clinics

Speaker information: Glenn Copeland, CEO and chief medical officer,  David Berman, chief financial officer

Time: 2 p.m. EST 

Company: ReShape Lifesciences Inc.

Ticker: RSLS 

Industry: Weight loss and metabolic health

Speaker information: Bart Bandy, CEO and president, Tom Stankovich, CFO

Time: 2:30  p.m. EST 

Company: Else Nutrition Holdings Inc.

Ticker: BABYF, BABY 

Industry: Plant-based nutrition

Speaker information: Hamutal Yitzhak, founder and CEO

Time: 3 p.m. EST 

Company: Salarius Pharmaceuticals, Inc.

Ticker: SLRX 

Industry: Biotechnology - Cancer

Speaker information: David Arthur, CEO

A complete list of the agenda is available on the Life Science Investor Forum’s main page. 

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.

Market News and Data brought to you by Benzinga APIs
Posted In: BiotechCannabisNewsPenny StocksEmerging MarketsMarketsGeneralOTC Markets GroupPartner Content
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!